186 related articles for article (PubMed ID: 15316302)
1. [Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy].
Colomba C; Scarlata F; Salsa L; Frasca Polara V; Titone L
Infez Med; 2004 Jun; 12(2):139-43. PubMed ID: 15316302
[TBL] [Abstract][Full Text] [Related]
2. [Childhood Mediterranean visceral leishmaniasis].
Cascio A; Colomba C
Infez Med; 2003 Mar; 11(1):5-10. PubMed ID: 12719664
[TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Minodier P; Retornaz K; Horelt A; Garnier JM
Fundam Clin Pharmacol; 2003 Apr; 17(2):183-8. PubMed ID: 12667228
[TBL] [Abstract][Full Text] [Related]
4. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
[TBL] [Abstract][Full Text] [Related]
5. Pediatric visceral leishmaniasis in southern France.
Minodier P; Piarroux R; Garnier JM; Unal D; Perrimond H; Dumon H
Pediatr Infect Dis J; 1998 Aug; 17(8):701-4. PubMed ID: 9726344
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and clinical features of visceral leishmaniasis in children in Alicante Province, Spain.
Ramos JM; Clavijo A; Moral L; Gavilan C; Salvador T; González de Dios J
Paediatr Int Child Health; 2018 Aug; 38(3):203-208. PubMed ID: 29790825
[TBL] [Abstract][Full Text] [Related]
7. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
[TBL] [Abstract][Full Text] [Related]
8. [Visceral childhood leishmaniasis: diagnosis and treatment].
Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
[TBL] [Abstract][Full Text] [Related]
9. [Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
Gradoni L; Gramiccia M; Scalone A
Parassitologia; 2004 Jun; 46(1-2):199-201. PubMed ID: 15305716
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
[TBL] [Abstract][Full Text] [Related]
11. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
[TBL] [Abstract][Full Text] [Related]
12. Mediterranean visceral leishmaniasis in pregnancy.
Gradoni L; Gaeta GB; Pellizzer G; Maisto A; Scalone A
Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563
[TBL] [Abstract][Full Text] [Related]
13. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of visceral leishmaniasis in children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of clinical and laboratory findings of adult visceral leishmaniasis cases].
Ural S; Kaptan F; Sezak N; El S; Örmen B; Türker N; Demirdal T; Vardar İ; Özkan Çayıröz P; Çakalağaoğlu F
Mikrobiyol Bul; 2015 Oct; 49(4):586-93. PubMed ID: 26649416
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
[TBL] [Abstract][Full Text] [Related]
17. [Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].
Marguglio A; Hoyoux C; Dresse MF; Chantraine JM; Thiry A; Gillet P
Arch Pediatr; 1998 Mar; 5(3):285-8. PubMed ID: 10327996
[TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
[TBL] [Abstract][Full Text] [Related]
19. Two cases of visceral leishmaniasis in Colombia resistant to meglumine antimonial treatment.
Vélez ID; Colmenares LM; Muñoz CA
Rev Inst Med Trop Sao Paulo; 2009; 51(4):231-6. PubMed ID: 19739006
[TBL] [Abstract][Full Text] [Related]
20. [Visceral leishmaniasis: new drugs].
Minodier P; Robert S; Retornaz K; Garnier JM
Arch Pediatr; 2003 Dec; 10 Suppl 5():550s-556s. PubMed ID: 15022780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]